Contrast-Enhanced MRA Used to Analyze Intracranial Aneurysms Treated by Flow-Diverting Stents

 

August 2, 2017—Long-term results of intracranial aneurysms treated with flow-diverting stents, with a focus on the usefulness of contrast-enhanced MRA, were reported by Maximilian Patzig, MD, et al online ahead of print in CardioVascular and Interventional Radiology.

The investigators analyzed interventions and follow-up imaging of patients with aneurysms treated by flow-diverting stents—including the Pipeline embolization device (Medtronic), the Silk device (Balt Extrusion), and the FRED flow-redirection endoluminal device (MicroVention Terumo)—without additional coiling.

All MRI scans included dedicated two-phase contrast-enhanced MRA. The investigators used MRI and digital subtraction angiography (DSA), where available, to evaluate aneurysm occlusion rates, aneurysm sac size, and complications. They graded the ability of contrast-enhanced MRA to depict aneurysm occlusion and stent patency on a three-point scale.

As summarized in CardioVascular and Interventional Radiology, the study included 25 patients with 102 MRI scans. The median duration of follow-up was 830 days. Aneurysm occlusion rates were 52% at 3 months (10 of 19 patients), 72% at 6 months (18/25), and 84% overall (21/25). Shrinkage of the aneurysm sac was found in 19 patients (76%) and in 12 patients to < 50% of the original size (48%). Contrast-enhanced MRA assessability of aneurysmal occlusion was graded as "good" in all cases. When compared to DSA (18 cases), contrast-enhanced MRA had a sensitivity of 100% and specificity of 91% regarding aneurysm remnant detection. The investigators noted that assessability of the stent lumen varied and was limited in most cases.

Flow-diverter treatment achieves high occlusion rates and can cause major aneurysm shrinkage. Contrast-enhanced MRA is highly valuable regarding imaging of the aneurysmal sac; however, there are limitations regarding the assessability of the stent lumen on contrast-enhanced MRA, concluded the investigators in CardioVascular and Interventional Radiology.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.